Company intelligence / Profile preview
Taisheng Zhiyao
Beijing, Beijing, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Taisheng Pharmaceutical is a clinical-stage biotechnology company based in Beijing, China, specializing in the discovery and development of innovative small molecule therapeutics. The company primarily focuses on oncology and endocrine-related diseases, with a particular emphasis on next-generation hormone receptor modulators. Its lead programs target the androgen and estrogen receptors to address unmet needs in prostate and breast cancers. Taisheng leverages its internal R&D capabilities to advance a pipeline of candidates through early-stage clinical trials in the Chinese market.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Taisheng Zhiyao.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Taisheng Zhiyao.